高级检索
当前位置: 首页 > 详情页

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

| |

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究单位: [1]Pfizer [2]The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China, 230022 [3]Second Affiliated hospital of Anhui Medical University Hefei, Anhui, China, 230601 [4]The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing, China, 400016 [5]The First hospital of LanZhou university Lanzhou, Gansu, China, 730000 [6]Breast Surgery of The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China, 510260 [7]SUN YAT-SEN Memorial Hospital , SUN YAT-SEN University Guangzhou, Guangdong, China, 510260 [8]Cancer Hospital of Shantou University Medical College Shantou, Guangdong, China, 515041 [9]Thyroid and breast surgery Shenzhen City, Guangdong, China, 518035 [10]Affiliated hospital of Guangdong medical college ZhanJiang, Guangdong, China, 524001 [11]Hainan General Hospital Haikou, Hainan, China, 570311 [12]Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050011 [13]Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China, 150081 [14]The First Affiliated Hospital of Xinxiang Medical University Weihui, Henan, China, 453100 [15]Henan Cancer Hospital Zhengzhou, Henan, China, 450000 [16]Henan provincial people's hospital Zhengzhou, Henan, China, 450000 [17]The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China, 450000 [18]Jingzhou Hospital Tongji Medical College Huazhong university of science and Technology Jingzhou, Hubei, China, 434020 [19]Breast and thyroid surgery of the Central Hospital of WuHan WuHan, Hubei, China, 430014 [20]Hunan Provincial People's Hospital Changsha, Hunan, China, 410005 [21]Xiangya Hospital Central South University /Department of Breast Changsha, Hunan, China, 410008 [22]The Affiliated Hospital of inner Mongolia medical university Hu He Hao Te, Inner Mongolia, China, 010021 [23]Changzhou No.2 People's Hospital Changzhou, Jiangsu, China, 213004 [24]Jiangsu Cancer Hospital/ Surgery Department Nanjing, Jiangsu, China, 210000 [25]Jinling Hospital Nanjing, Jiangsu, China, 210002 [26]Jiangsu Province Hospital/ Surgery Department Nanjing, Jiangsu, China, 210029 [27]Nanjing Maternity and Child Health Care Hospital/Department of Breast Surgery Nanjing, Jiangsu, China [28]Suzhou Municipal Hospital Suzhou, Jiangsu, China, 215002 [29]The first hospital of jilin university Changchun, Jilin, China, 130021 [30]The Fourth Affiliated Hospital Of China Medical University ShenYang, Liaoning, China, 110032 [31]The First Affiliated Hospital of The Fourth Military Medical University Xi'an, Shaanxi, China, 710032 [32]The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China, 710061 [33]Linyi People's Hospital Linyi, Shandong, China, 276000 [34]The Affiliated Hospital of Qingdao University Qingdao, Shandong, China, 266061 [35]Qingdao municipal Hospital Qingdao, Shandong, China, 266072 [36]Breast Surgery of The Weifang People's Hospital Weifang, Shandong, China, 261041 [37]Breast Surgery of YanTai Yu Huang Ding Hospital Yan Tai, Shandong, China, 264000 [38]Breast and thyroid surgery of Central Hospital of Zibo Zibo, Shandong, China, 255036 [39]West China Hospital, Sichuan University/ Oncology Department Chengdu, Sichuan, China, 610041 [40]Sichuan Provincial People's Hospital Chengdu, Sichuan, China, 610072 [41]Affiliated Hospital of North Sichuan Medical College Nanchong, Sichuan, China, 637000 [42]Tianjin Cancer Hospital/Breast cancer department Tianjin, Tianjin, China, 300060 [43]Affiliated Cancer Hospital of Xinjiang Medical University Urumchi, Xinjiang, China, 830000 [44]Yunnan Cancer Hospital Kunming, Yunnan, China, 650118 [45]Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 [46]Cancer Hospital Chinese Academy of medical sciences Beijing, China, 100021 [47]Fifth Medical Center of the PLA General Hospital Beijing, China, 100071 [48]Beijing Cancer Hospital Beijing, China, 100142 [49]Peking University Third Hospital/Department of Oncology Beijing, China, 100191 [50]China-Japan Friendship Hospital Beijing, China [51]Fudan University Shanghai Cancer center/Department of Breast Surgery Shanghai, China, 200032 [52]Yangpu District Central Hospital Shanghai, China, 200090 [53]Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai, China, 200092 [54]The First Affiliated Hospital of Bengbu Medical College/Medical Oncology Department Bengbu, Anhui, China, 233004

关键词: breast cancer Aromasin adjuvant chemotherapy endocrine therapy

研究目的:
Aromasin® (Exemestane) was approved in China for adjuvant treatment of postmenopausal women with estrogen receptor (ER) positive early invasive breast cancer who have received 2-3 years of tamoxifen & are switched to Aromasin® for completion of a total of 5 consecutive years of adjuvant hormonal therapy by State Food and Drug Administration (SFDA) with clinical trial waive. While Aromasin® has been used in China for adjuvant therapy of breast cancer since then, there is currently lack of systematic collection and analysis for the efficacy and safety data of Aromasin® adjuvant setting in Chinese population. The Aromasin® Interventional Study is being proposed to collect data systematically and to assess the efficacy and safety of Aromasin® adjuvant setting in Chinese population.

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号